Docosahexaenoic Acids: all 100 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Dihydroartemisinin for Treating Female Androgenetic AlopeciaRecruitingNCT07012486Early Phase 1
- The Developmental Origins of ObesityRecruitingNCT06981676Not applicable
- Differential Thrombogenesis by EPA and DHA Mediated by HDLRecruitingNCT06494488Early Phase 1
- Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth RestrictionRecruitingNCT05038462Not applicable
- Docosahexaenoic Acid on Breath Holding Spells in ChildrenRecruitingNCT03965988Phase 3
- Omega Tots Long Term Follow-upActive, not recruitingNCT05191823Not applicableResults posted
- Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older AdultsCompletedNCT03576989Not applicableResults posted
- Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and LipidsCompletedNCT02670382Not applicableResults posted
- Improving Maternal and Child Health Through Prenatal Fatty Acid SupplementationActive, not recruitingNCT02647723Not applicableResults posted
- Kansas University DHA Outcome Study (KUDOS) Follow-UpCompletedNCT02487771Phase 3Results posted
- The Effects of DHA on PeriodontitisCompletedNCT01976806Phase 2Results posted
- DHA For The Treatment of Pediatric Concussion Related to Sports InjuryCompletedNCT01903525Phase 1Results posted
- Effect of Omega-3 Fatty Acid on Cortical Function in ADHDCompletedNCT01883817Phase 3Results posted
- Effects of DHA on Pro-resolving Anti-inflammatory Mediators in Obese Patients Undergoing Weight-loss TreatmentCompletedNCT01865448Not applicableResults posted
- Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsCompletedNCT01849250Phase 2Results posted
- Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB PatientsCompletedNCT01826422Not applicableResults posted
- High Dose Omega-3 Fatty Acids in the Treatment of Sport Related ConcussionsCompletedNCT01814527Not applicableResults posted
- Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer PreventionCompletedNCT01661764Phase 2Results posted
- Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental OutcomesCompletedNCT01576783Phase 4Results posted
- Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty AcidsCompletedNCT01563913Phase 1Results posted
- Effect of Omega-3 Supplementation During Pregnancy on Regulation of StressCompletedNCT01158976Not applicableResults posted
- Dose Response Effects of Marine Omega-3 Fatty Acids on InflammationCompletedNCT01078909Phase 3Results posted
- Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac OutcomesCompletedNCT01007110Phase 3Results posted
- DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseCompletedNCT00440050Phase 3Results posted
- Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major DepressionCompletedNCT00361374Phase 3Results posted
- Age-Related Eye Disease Study 2 (AREDS2)CompletedNCT00345176Phase 3Results posted
- DHA Supplementation and Pregnancy OutcomeCompletedNCT00266825Phase 3Results posted
- Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm LaborCompletedNCT06302023Phase 2
- A Dose Response Investigation of Docosahexaenoic Acid (DHA)CompletedNCT06294067Phase 1
- Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical TrialActive, not recruitingNCT06207071Not applicable
- Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative StudyActive, not recruitingNCT05915806Not applicable
- Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With GlaucomaCompletedNCT05527106Not applicable
- The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild DementiaCompletedNCT04972643Not applicable
- Effect of DHA on Proinflammatory Cytokines Including Platelets Activating Factor (PAF) in Preterm NeonatesCompletedNCT04746885Not applicable
- Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected PatientsStatus unknownNCT04242004Phase 1/2
- Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)CompletedNCT04128449Not applicable
- Docosahexaenoic Acid (DHA) Supplementation in High Risk PregnanciesStatus unknownNCT04069195Not applicable
- Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking StatinsCompletedNCT03961763Not applicable
- Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant SettingActive, not recruitingNCT03831178Phase 2
- Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish SoftgelsStatus unknownNCT03781557Phase 4
- The Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm NeonatesStatus unknownNCT03700957Not applicable
- DHA Brain Delivery TrialCompletedNCT03613844Phase 2
- The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby PlayersCompletedNCT03582267Not applicable
- Impact of DHA/Oat on Metabolic Health in Gestational Diabetes MellitusStatus unknownNCT03569501Not applicable
- Docosahexaenoic Acid (DHA) Supplementation in AmblyopiaWithdrawnNCT03402789Phase 1/2
- Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular DystrophiesCompletedNCT03317171Not applicable
- Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38CompletedNCT03109626Not applicable
- Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in InfantsCompletedNCT03014115Not applicable
- Dose-Finding Study of SC411 in Children With Sickle Cell DiseaseStatus unknownNCT02973360Phase 2
- Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male FertilityCompletedNCT02889341Not applicable
- Prenatal DHA and Neurofunctional DevelopmentCompletedNCT02709239Not applicable
- Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)CompletedNCT02690857Phase 2
- Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of PrematurityCompletedNCT02683317Not applicable
- Assessment of DHA On Reducing Early Preterm BirthCompletedNCT02626299Phase 3
- A Sickle CEll Disease ComplicatioN TrialStatus unknownNCT02604368Phase 3
- Fish Oil Brain Delivery StudyCompletedNCT02541929Phase 2/3
- Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to ChemotherapyCompletedNCT02517502Early Phase 1
- A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersStatus unknownNCT02336243Phase 3
- DHA Supplementation and Pregnancy OutcomeCompletedNCT02219399Not applicable
- Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial HealthWithdrawnNCT02137408Not applicable
- DHA and Vitamin D in Children With Biopsy-proven NAFLDCompletedNCT02098317Phase 3
- The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of PregnancyWithdrawnNCT01965054Not applicable
- Effect of Mother DHA Supplementation on Term Newborn.CompletedNCT01947426Phase 2/3
- Effect of Mother DHA Supplementation on Premature Newborn.CompletedNCT01940640Phase 2/3
- The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic DermatitisWithdrawnNCT01936194Not applicable
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisCompletedNCT01934777Phase 3
- The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With AsthenozoospermiaCompletedNCT01846325Phase 2/3
- The Effects of DHA on Attention Deficit and Hyperactivity DisorderCompletedNCT01796262Phase 3
- Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm NeonatesCompletedNCT01745510Phase 1/2
- The Impact of Fish-oil Fatty Acids on Postprandial Vascular ReactivityCompletedNCT01692431Not applicable
- Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.CompletedNCT01580345Phase 3
- The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and AggressionCompletedNCT01558193Not applicable
- The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHDCompletedNCT01554462Not applicable
- Effect of Dietary DHA Supplementation on Sperm QualityCompletedNCT01368484Not applicable
- Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette SmokersCompletedNCT01284660Not applicable
- Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical TrialActive, not recruitingNCT01260961Not applicable
- Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in AsthmaCompletedNCT01200446Not applicable
- Cheek Cells - Non-invasive Fatty Acid Status MarkerCompletedNCT01192269Not applicable
- The DHA (Docosahexaenoic Acid) Oxford Learning and Behaviour (DOLAB) StudyCompletedNCT01066182Phase 2
- Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic LeukemiaCompletedNCT01051154Phase 2
- Effect of Docosahexaenoic Acid on the Inflammatory Response and Clinical Outcomes From Surgical PatientsCompletedNCT01049529Phase 2
- Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched OilCompletedNCT00988585Phase 1
- Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler CognitionCompletedNCT00982462Not applicable
- Oral Docosahexanoic Acid Supplementation in Cystic FibrosisCompletedNCT00924547Phase 2
- The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)CompletedNCT00892554Not applicable
- Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00885313Phase 1/2
- Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly PatientsCompletedNCT00749307Phase 2/3
- Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility StudyWithdrawnNCT00691418Not applicable
- Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) StatusCompletedNCT00678067Not applicable
- Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic FunctionCompletedNCT00662142Phase 3
- Effects of Prenatal DHA Supplements on Infant DevelopmentCompletedNCT00646360Not applicable
- Effects of Omega-3 Fatty Acids on Bone and FrailtyStatus unknownNCT00634686Phase 4
- Docosaexahenoic Acid and Gross Motor Milestones in InfantsCompletedNCT00610922Not applicable
- Docosahexaenoic Acid in the Treatment of AutismCompletedNCT00577447Not applicable
- Use of Formula Fortified With DHA in Infants With Cystic FibrosisCompletedNCT00530244Not applicable
- The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill PatientsCompletedNCT00487097Not applicable
- The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or DiabetesCompletedNCT00360217Not applicable
- Evaluation of DHA for the Treatment of PSCCompletedNCT00325013Phase 1
- Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosaCompletedNCT00004827Not applicable
- Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin ACompletedNCT00000116Phase 3